Dynatrace, Inc.DT
Dynatrace, Inc. Income Taxes Disclosure
Income Taxes
Income tax provision
Income before income taxes includes the following (in thousands):
| Fiscal Year Ended March 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Domestic | $ | 138,333 | $ | 82,033 | $ | 63,869 | |||||||||||
| Foreign | 85,096 | 72,882 | 26,098 | ||||||||||||||
| Total | $ | 223,429 | $ | 154,915 | $ | 89,967 | |||||||||||
The income tax provision includes the following (in thousands):
| Fiscal Year Ended March 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Current tax position: | |||||||||||||||||
| Federal | $ | 93,563 | $ | 44,568 | $ | 11,947 | |||||||||||
| State | 5,530 | (6,236) | 8,071 | ||||||||||||||
| Foreign | 33,729 | 21,839 | 15,335 | ||||||||||||||
| Total current tax position | 132,822 | 60,171 | 35,353 | ||||||||||||||
| Deferred tax provision: | |||||||||||||||||
| Federal | (58,527) | (52,712) | (50,345) | ||||||||||||||
| State | (4,201) | (3,500) | (1,689) | ||||||||||||||
| Foreign | (330,349) | (3,676) | (1,311) | ||||||||||||||
| Total deferred tax provision | (393,077) | (59,888) | (53,345) | ||||||||||||||
| Total income tax (benefit) expense | $ | (260,255) | $ | 283 | $ | (17,992) | |||||||||||
During the year ended March 31, 2025, the Company completed an intra-entity asset transfer of the global economic rights of Dynatrace IP from a wholly-owned U.S. subsidiary to a wholly-owned Swiss subsidiary, more closely aligning the Company’s IP rights with its business operations (the “IP Transfer”). The transaction is taxable in the U.S. over a 20-year period. In Switzerland, the transaction resulted in a step-up of tax-deductible basis in the transferred assets, and accordingly, created a temporary difference where the tax basis exceeded the financial statement basis of such intangible assets, which resulted in the recognition of a tax benefit and related deferred tax asset of $320.9 million. The Company determined the estimated value of the transferred IP based principally on the present value of projected income related to the IP, requiring management to make significant assumptions related to the discount rate and the forecast of future revenues and expenses. The tax-deductible amortization related to the transferred IP rights will be recognized over 10 years. The deferred tax asset and the tax benefit were measured based on the enacted tax rates expected to apply in the years the asset is expected to be realized. The Company expects to realize the deferred tax asset resulting from the IP Transfer.
The Company’s income tax expense (benefit) differs from the amounts computed by applying the U.S. federal income tax rate of 21% for the years ended March 31, 2025, 2024 and 2023 to pre-tax income, as a result of the following (in thousands):
| Fiscal Year Ended March 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Income tax expense at U.S. federal statutory income tax rate | $ | 46,920 | $ | 32,532 | $ | 18,893 | |||||||||||
| State and local tax expense, net of federal benefits | 7,296 | 306 | 1,421 | ||||||||||||||
| Foreign tax rate differential | 2,129 | 3,318 | 1,770 | ||||||||||||||
| U.S. effects of foreign branch income | 12,147 | 8,662 | 1,519 | ||||||||||||||
| Non-taxable income and non-deductible expenses | 860 | 1,742 | 1,216 | ||||||||||||||
| Tax credits | (58,761) | (41,740) | (26,457) | ||||||||||||||
| GILTI inclusion and FDII deduction | (14,563) | (13,905) | (10,938) | ||||||||||||||
| Employee compensation | 8,622 | (7,188) | 5,528 | ||||||||||||||
| Changes in uncertain tax positions | 6,534 | (14,835) | 10,978 | ||||||||||||||
| Changes in valuation allowance | 27,116 | 13,080 | (32,629) | ||||||||||||||
| Foreign withholding tax | 18,414 | 18,469 | 12,598 | ||||||||||||||
| Inflation and currency related adjustments | 100 | 851 | (1,518) | ||||||||||||||
| Intra-entity transfer of IP | (320,902) | — | — | ||||||||||||||
| Other adjustments | 3,833 | (1,009) | (373) | ||||||||||||||
| Total income tax (benefit) expense | $ | (260,255) | $ | 283 | $ | (17,992) | |||||||||||
Management’s analysis of all available positive and negative evidence as of March 31, 2025 resulted in the conclusion that the net deferred tax assets related to U.S. state and local jurisdictions, with the exception of certain state attributes, are more likely than not to be utilized. As such, the valuation allowance previously recorded against such net deferred tax assets has been reversed accordingly, resulting in a net income tax benefit of $4.8 million.
As of March 31, 2025, the Company continues to maintain a valuation allowance of $38.7 million with respect to certain U.S. federal and state deferred tax assets that, due to their nature, are not likely to be realized. In addition, the Company continues to maintain a valuation allowance of $29.5 million with respect to its deferred tax assets in certain non-U.S. jurisdictions. The net change in the valuation allowance during the year ended March 31, 2025 was $27.7 million, of which $27.1 million impacted tax expense.
Temporary differences and carryforwards that give rise to a significant portion of deferred tax assets and liabilities are as follows (in thousands):
| March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Deferred tax assets: | |||||||||||
| Deferred revenue | $ | 32,055 | $ | 26,088 | |||||||
| Capitalized research and development costs | 155,368 | 106,836 | |||||||||
| Accrued expenses | 21,829 | 20,284 | |||||||||
| Share-based compensation | 28,012 | 28,518 | |||||||||
| Operating lease liabilities | 24,249 | 14,892 | |||||||||
| Net operating loss carryforwards | 24,312 | 10,998 | |||||||||
| Intangible assets | 303,835 | — | |||||||||
| Tax credit carryforwards | 59,599 | 29,822 | |||||||||
| Other | 4,683 | 3,070 | |||||||||
| Total deferred tax assets | 653,942 | 240,508 | |||||||||
| Valuation allowance | (68,222) | (40,530) | |||||||||
| Total deferred tax assets, net valuation allowance | 585,720 | 199,978 | |||||||||
| Deferred tax liabilities: | |||||||||||
| Intangible assets | — | 12,880 | |||||||||
| Operating lease right-of-use assets | 22,267 | 12,826 | |||||||||
| Deferred commissions | 33,632 | 33,798 | |||||||||
| Other | 690 | 2,651 | |||||||||
| Total deferred tax liabilities | 56,589 | 62,155 | |||||||||
| Net deferred tax assets | $ | 529,131 | $ | 137,823 | |||||||
At March 31, 2025, the Company had non-U.S. net operating loss carryforwards of $133.8 million, of which $91.2 million expire in periods through 2045 if not utilized, and the remaining balance of $42.6 million may be carried forward indefinitely. The Company also had non-U.S. tax credit carryforwards of $19.3 million, of which $19.1 million expire in periods through 2030 if not utilized, and the remaining balance of $0.2 million may be carried forward indefinitely. Deferred tax assets of $26.2 million related to non-U.S. net operating losses and tax credit carryforwards are subject to valuation allowances as of March 31, 2025.
At March 31, 2025, the Company had U.S. state and local net operating loss carryforwards of $45.5 million, of which $41.3 million expire in periods through 2043 if not utilized, and the remaining balance of $4.2 million may be carried forward indefinitely. The Company also had U.S. federal tax credit carryforwards of $40.3 million, which expire in periods through 2035. Deferred tax assets of $38.7 million primarily related to U.S. federal tax credit carryforwards are subject to valuation allowances as of March 31, 2025.
During the fiscal year ended March 31, 2025, the Company made the determination that the unremitted foreign earnings associated with certain of its foreign subsidiaries are no longer indefinitely reinvested as a result of the IP Transfer. The Company recorded a deferred tax liability of $0.1 million related to the taxes expected to be imposed upon the repatriation of these unremitted foreign earnings that are not considered indefinitely reinvested. The Company has not provided for taxes on the excess of the amount for financial reporting over the tax basis of investments in certain other foreign subsidiaries in which the Company maintains its assertion that it intends these earnings to be indefinitely reinvested. Generally, these earnings will be treated as previously taxed income from either the one-time transition tax or GILTI, or they will be offset with a 100% dividend received deduction. The income taxes applicable to repatriating such earnings are not readily determinable.
Uncertain tax positions
The amount of gross unrecognized tax benefits (“UTBs”) was $20.2 million and $13.7 million as of March 31, 2025 and 2024, respectively, all of which would favorably affect the Company’s effective tax rate if recognized in future periods.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits for the years ended March 31, 2025, 2024, and 2023 (in thousands):
| Fiscal Year Ended March 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Gross unrecognized tax benefit, beginning of year | $ | 13,668 | $ | 29,110 | $ | 15,017 | |||||||||||
| Gross increases to tax positions for the current period | 6,725 | — | — | ||||||||||||||
| Gross increases to tax positions for prior periods | 1,689 | 721 | 16,471 | ||||||||||||||
| Gross decreases to tax positions for prior periods | — | (4,277) | (808) | ||||||||||||||
| Decreases related to settlements | — | (168) | (625) | ||||||||||||||
| Decreases due to lapse of statutes of limitations | (1,922) | (11,689) | (832) | ||||||||||||||
| Foreign currency translation | $ | 8 | $ | (29) | $ | (113) | |||||||||||
| Gross unrecognized tax benefit, end of year | $ | 20,168 | $ | 13,668 | $ | 29,110 | |||||||||||
As of March 31, 2025 and 2024, the net interest and penalties payable associated with uncertain tax positions was $0.9 million and $1.1 million, respectively. During the years ended March 31, 2025, 2024, and 2023, the Company recognized a benefit of $0.3 million, $1.4 million, and expense of $1.0 million, respectively, related to interest and penalties.
The Company files tax returns in U.S. federal, state, and foreign jurisdictions and the tax returns are subject to examination by various domestic and international tax authorities. As of March 31, 2025, the Company has open U.S. federal tax years back to fiscal year 2022. The Company also has open years in certain significant state jurisdictions back to fiscal year 2019, and foreign jurisdictions back to 2015. These open years contain matters that could be subject to differing interpretations of applicable tax laws and regulations due to the amount, timing or inclusion of revenue and expenses. It is reasonably possible that approximately $3.0 million of certain U.S. and foreign UTBs may be recognized within the next 12 months as a result of a lapse in the statute of limitations.
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.